Myriad Genetics | MYGN - Ebitda

Cena Akcji
3.81
Dzienna Zmiana
0.26 7.32%
Miesięcznie
-23.65%
Rocznie
-6.39%
Q2 Prognozy TE
3.51




Ebitda Zmiana Data
Agilent USD 540M 74M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Bruker USD 110M 101.6M 2026-03
Danaher USD 1.92B 204M 2026-03
Illumina USD 469M 137M 2025-12
J&J USD 7.19B 2.32B 2025-12
Mettler Toledo International USD 278.99M 100.24M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quest Diagnostics USD 557M 20M 2026-03
Quidel USD 108.7M 44.6M 2026-03
Repligen USD 40.01M 469K 2026-03
Revvity USD 272.91M 24M 2026-03
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Veracyte USD 42.8M 488K 2026-03
Waters USD 380.97M 85.83M 2025-12